Sign in
4

Changes in Ownership

Passage BIO, Inc. Filed Acc 0001209191-21-023476

Options or other derivatives

  • Chief Res. & Develop Officer acquired 375,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Salinas Eliseo Oreste Chief Res. & Develop Officer 2021-03-22 Grant or award · Employee Stock Option (Right to buy) +275,000 275,000 D
Salinas Eliseo Oreste Chief Res. & Develop Officer 2021-03-22 Grant or award · Restricted Stock Unit (RSU) +40,000 40,000 D
Salinas Eliseo Oreste Chief Res. & Develop Officer 2021-03-22 Grant or award · Restricted Stock Unit (RSU) +60,000 60,000 D
Loading xslF345X03/doc4.xml…